Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| IN-US-380-7737 | Other Grant/Funding Number | Gilead |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The BEYOND Study aims to evaluate HIV treatment outcomes and well-being among young men who have sex with men (YMSM) living with HIV in Ho Chi Minh City, Vietnam. Despite progress in HIV services, YMSM continue to experience disparities in engagement in care, antiretroviral therapy (ART) adherence, and viral suppression, influenced by individual, social, and structural factors including stigma and limited access to person-centered care.
This prospective cohort study will enroll 300 YMSM living with HIV from four clinical sites, including public, private, and community-based clinics. Participants will be followed for 12 months, with data collection at baseline, 6 months, and 12 months. The study will assess key outcomes including viral suppression, ART adherence, retention in care, mental health, and quality of life. In addition, in-depth interviews will be conducted with a subset of 20-30 participants to explore experiences with HIV care and barriers and facilitators to engagement.
The study will also examine the implementation and perceived impact of person-centered care and one-stop-shop service models across different healthcare settings. Findings from this study will inform strategies to improve HIV treatment outcomes and support the development of integrated, patient-centered approaches to care for YMSM living with HIV in Vietnam and similar settings.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Young MSM Living With HIV | Young men who have sex with men (YMSM) living with HIV enrolled from public, private, and community-based clinics in Ho Chi Minh City, Vietnam. Participants are followed prospectively for 12 months with assessments at baseline, 6 months, and 12 months to evaluate HIV treatment outcomes, including viral suppression, antiretroviral therapy adherence, retention in care, mental health, and quality of life. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| NO interventions listed | Other | NO interventions listed |
|
| Measure | Description | Time Frame |
|---|---|---|
| Viral Suppression Rate at 6 Months (HIV RNA <200 copies/mL) | Proportion of participants achieving viral suppression, defined as HIV RNA <200 copies/mL, based on clinical records. Participants lost to follow-up or with missing viral load data will be classified as not virally suppressed in the primary analysis | 6 months after enrollment |
| Viral Suppression Rate at 12 Months (HIV RNA <200 copies/mL) | Proportion of participants achieving viral suppression, defined as HIV RNA <200 copies/mL, based on clinical records. Participants lost to follow up or with missing viral load data will be considered not virally suppressed in the primary analysis. | 12 months after enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| ART Adherence (≥95% of Prescribed Doses, 30-Day Recall) | Proportion of participants achieving optimal adherence to antiretroviral therapy, defined as ≥95% of prescribed doses taken over the past 30 days, assessed using clinical records. | 6 months and 12 months after enrollment |
| Depressive Symptoms (Center for Epidemiologic Studies Depression Scale-Revised [CESD-R] Total Score) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Young men who have sex with men (YMSM) aged 18-24 years living with HIV in Ho Chi Minh City, Vietnam, recruited from public, private, and community based clinics providing HIV care and related services.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| An Bao, Master of Public Health | Contact | 0084913650536 | baoan.lab@gmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| GoVap, MaiKhoi, Galant, Xomchieu | Recruiting | Ho Chi Minh City | Vietnam |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D015658 | HIV Infections |
| D000092862 | Psychological Well-Being |
| D055118 | Medication Adherence |
| ID | Term |
|---|---|
| D000086982 | Blood-Borne Infections |
| D003141 | Communicable Diseases |
| D007239 | Infections |
| D015229 | Sexually Transmitted Diseases, Viral |
Not provided
Not provided
Not provided
Not provided
Not provided
Depressive symptoms assessed using the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R). Items are scored on a scale of 0 to 4, with higher scores indicating greater severity of depressive symptoms. |
| Baseline, 6 months, and 12 months |
| Experience of Person-Centered HIV Care (Qualitative Assessment via In-Depth Interviews) | Participant reported experience and perceived quality of person-centered HIV care and integrated service delivery assessed through in depth interviews. | At a single time point during the 12 month follow up |
| Overall Depression Severity and Impairment (Overall Depression Severity and Impairment Scale [ODSIS] Total Score) | Depression severity and functional impairment assessed using the Overall Depression Severity and Impairment Scale (ODSIS). Total scores range from 0 to 20 (5 items scored 0-4), with higher scores indicating greater depression severity and impairment | Baseline, 6 months, and 12 months |
| Anxiety Severity and Impairment (Overall Anxiety Severity and Impairment Scale [OASIS] Total Score) | Anxiety severity and functional impairment assessed using the Overall Anxiety Severity and Impairment Scale (OASIS). Total scores range from 0 to 20 (5 items scored 0-4), with higher scores indicating greater anxiety severity and impairment. | Baseline, 6 months, and 12 months |
| Perceived Social Support (Multidimensional Scale of Perceived Social Support [MSPSS] Mean Score) | Perceived social support assessed using the Multidimensional Scale of Perceived Social Support (MSPSS). Items are scored on a scale from 1 to 7, with higher scores indicating greater perceived social support. | Baseline, 6 months, and 12 months |
| D012749 | Sexually Transmitted Diseases |
| D016180 | Lentivirus Infections |
| D012192 | Retroviridae Infections |
| D012327 | RNA Virus Infections |
| D014777 | Virus Diseases |
| D000091662 | Genital Diseases |
| D000091642 | Urogenital Diseases |
| D007153 | Immunologic Deficiency Syndromes |
| D007154 | Immune System Diseases |
| D010549 | Personal Satisfaction |
| D001519 | Behavior |
| D010349 | Patient Compliance |
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |